China Looks to Change Import Drug Registration System

The Chinese FDA is proposing to relax restrictions on imported drugs by no longer requiring that foreign drugs be approved abroad, or in late-stage clinical trials, before an international multi-center trial can be started in China to seek an approval.
Source: Drug Industry Daily